Deferred Tax Assets, Valuation Allowance in USD of Tonix Pharmaceuticals Holding Corp. from Q4 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2011 to Q4 2024.
  • Tonix Pharmaceuticals Holding Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $62,871,000, a 38% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Tonix Pharmaceuticals Holding Corp. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $62,871,000 +$17,387,000 +38% 31 Dec 2024 10-K 18 Mar 2025 2024 FY
Q4 2023 $45,484,000 +$14,492,000 +47% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q4 2022 $30,992,000 +$9,578,000 +45% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $21,414,000 +$15,339,000 +252% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q4 2020 $6,075,000 +$2,201,000 +57% 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q4 2019 $3,874,000 +$226,000 +6.2% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q4 2018 $3,648,000 +$324,000 +9.7% 31 Dec 2018 10-K 24 Mar 2020 2019 FY
Q4 2017 $3,324,000 -$13,883,000 -81% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q4 2016 $17,207,000 +$1,758,000 +11% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q4 2015 $15,449,000 +$2,223,000 +17% 31 Dec 2015 10-K 13 Apr 2017 2016 FY
Q4 2014 $13,226,000 +$3,796,714 +40% 31 Dec 2014 10-K 03 Mar 2016 2015 FY
Q4 2013 $9,429,286 +$4,068,336 +76% 31 Dec 2013 10-K 27 Feb 2015 2014 FY
Q4 2012 $5,360,950 +$2,891,718 +117% 31 Dec 2012 10-K 28 Mar 2014 2013 FY
Q4 2011 $2,469,232 31 Dec 2011 10-K/A 22 Nov 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.